中文摘要
砷化物是廣泛存在於自然環境中的毒性物質，與人類皮膚癌、肺癌及肝癌的發生息息相關。近年來許多學者的研究指出，砷化物所造成的毒性與砷化物會產生自由基有關。在細胞中為了抵抗氧化壓力，細胞自己便會發展許多防禦的機制。Thioredoxin peroxidase II（TPxII）是一種受氧化性壓力（oxidative stress）誘導的酵素，也是一新發現的抗氧化蛋白質，其功能涵蓋細胞的分裂及分化、保護其他蛋白質免於受到氧化傷害、參與細胞中訊息的傳遞。
在本論文中，我們研究不同砷化物對各種哺乳類細胞中TPx II表現的影響及調控機制。由結果發現，在SA7N細胞中，亞砷酸鈉會誘發TPx II大量表現。而對其他細胞株例如：H1299、H460、HFW、IRC、KB、HaCaT等，亞砷酸鈉則無法誘導其TPx II大量表現。此外，也發現在亞砷酸鈉處理下，SA7N細胞內過氧化氫（H2O2）的累積量有增加的現象，顯示亞砷酸鈉誘導TPx II的表現，可能與其透過對細胞產生氧化性壓迫有關。
我們進一步以SA7N細胞研究亞砷酸鈉誘導TPx II表現的訊號傳遞途徑。結果顯示蛋白質激酶C（PKC）的抑制劑包括Rottlerin，Staurosprine可以抑制亞砷酸鈉所誘導TPx II的表現，而且在鈣離子
螯合劑EGTA和BAPTA/AM的處理下，亞砷酸鈉所誘導的TPx II大量表現也都沒有被抑制。進一步研究發現，對PKCδ有高專一性的抑制劑G06983、Calphostin C也可以有效地抑制亞砷酸鈉誘導TPx II的表現。而蛋白質激酶A（PKA）抑制劑（H89）、ERK抑制劑（PD98059）、p38抑制劑（SB203580）、酪胺酸激酶抑制劑（Genistein）則都無法抑制TPx II的表現。此一結果顯示，蛋白質激酶Cδ可能參與在SA7N細胞中亞砷酸鈉誘導TPx II的表現。

Abstract
Arsenic is a common environmental toxicant associated with human skin, lung and liver cancers. Recently, numerous studies suggested that arsenic-induced toxicity is associated with the generation of free radicals. To cope with the oxidative stress, the cell has developed various defense mechanism. Thioredoxin peroxidase II (TPx II) is an oxidative stress-inducible enzyme. TPx II functions in cell proliferation and differentiation, and protects other proteins from oxidative damage.
In this study, we investigate the effect of arsenic compounds on the expression of TPx II. The results showed that arsenite induces TPx II protein expression in SA7N cell (a revertant of arsenic resistant Chinese hamster ovary cells), but not in other cell lines such as H1299、H460、HFW、IRC、KB、HaCaT. Moreover, the induction of TPx II also accompanied with H2O2 accumulation in SA7N cells. We therefore further explore the signaling pathway involved in TPx II induction by arsenite in SA7N cells. The results showed that pre-treatment of SA7N cells with inhibitors of protein kinase A (PKA), extracellular-regulated kinase (ERK), p38 and tyrosine kinase had no effect on the induction of TPx-II expression by arsenite. Calcium chelators, such as EGTA and BAPTA/AM, also showed no effect on TPx-II induction by arsenite. However, arsenite-induced TPx-II expression was dose-dependently reduced by two broad–based protein kinase C (PKC) inhibitors, Rottlerin and Staurosprine. Furthermore, two highly specific inhibitors of PKCδ, Go6983 and Calphostin C ,
also decreased arsenite-induced TPx II expression. The present results suggested that PKCδ might be involved in arsenite-induced TPx II expression in SA7N cells.

第五章 參考文獻
李世瑛. 2001. Thioredoxin Peroxidase II蛋白與亞砷酸鈉毒性與結合作用之研究. 國立中央大學碩士論文.
Aposhian, H. V. （1989）Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 10: 265-299.
Applegate, L. A., P. Lushcher, and R. M. Tyrrell (1991) Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51: 974-978.
Berolero, F., G. Pozzi, E. Sabbioni, and U. Saffiotti (1987) Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation.　Carcinogenesis 8: 803-808.
Bogdan, G. M., A. Sampayo-Reyes, and H. V. Aposhian (1994) Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93: 175-193.
Buchet, J. P., and R. Lauwerys (1985) Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observation in man. Arch. Toxicol. 57: 125-129.
Carlson-Lynch, H., B. D. Beck, and P. D. Boardman (1994) Arsenic risk assessment.Environ. Health Perspect. 102: 354-356.
Chae, H. Z., H. J. Kim, S. W. Kang, and S. G. Rhee (1999) Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes. Res. Clin. Pract. 45: 101-112.
Chae, H. Z., I. H. Kim, K. Kim, and S. G. Rhee (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268: 16815-16821.
Chae, H. Z., S. J. Kim, S. W. Chung, and S. G. Rhee (1994) Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269: 27670-27678.
Chae, H. Z., K. Robison, L. B. Poole, G. Church, and S. G. Rhee (1994) Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. U.S.A. 91: 7017-7021.
Chen, C. J., Y. C. Chuang, T. M. Lin, and H. Y. Wu (1985) Malignant neoplasms among residents of a blackfoot diease-endemic area in Taiwan: hight-arsenic artesian well water and cancers. Cancer Res. 45: 5895-5899.
Chen, C. J., Y. M. Hsueh, M. S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25: 53-60.
Chen, G. Q., J. Zhu, X. G. Shi, J. H. Ni, H. J. Zhong, G. Y. Si, X. L. Jin, W. Tang, X. S. Li, S. M. xong, Z. X. Shen, G. L. Sun, J. Ma, P. Zhang, T. D. Zhang, C. Gazin, T. Naoe, S. J. Chen, Z. Y. Wang, and Z. Chen (1996) In virto studies on cellular and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88: 1052-1061.
Chen, H. Z., I. H. Kim, K. Kim, and S. G. Rhee (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268: 16815-16821.
Chen, M. L., R. S. King, and H. J. Armbrecht (1990) Sodium-dependent phosphate transport in primary cultures of renal tubule cells from young and adult rats. J. Cell. Physiol. 143: 488-493.
Crecelius, E. A. (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19: 147-150.
Del Razo, L. M., M. A. Arellano, and M. E. Cebrian (1990) The oxidation states of arsenic in well-water from a chronic arsenicism of Northern Mexico. Environ. Pollut. 64: 143-153.
Fan, S. R., I. C. Ho, F. L. Yeoh, C. J. Lin, and T. C. Lee (1996) Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Mutat. Res. 368: 165-169.
Fischer, A. B., J. P. Buchet, and R. Lauwerys (1985) Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57: 168-172.
Gorbsky, G. J. (1994) Arsenic in human medicine, arsenic in the environment. Part2: Human health and ecosystem effects, New York.
Gurley, L. R., R. A. Walters, J. H. Jett, and R. A. Tobey (1980) Response of CHO cell proliferation and histone phosphorylation to sodium arsenite. J. Toxicol. Environ. Health. 6: 87-105.
Huang, R. N., and T. C. Lee (1996) Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol. Appl. Pharmacol. 136: 243-249.
IARC. (1980) Carcinogenesis of arsenic and arsenic compounds. IARC. 23: 37-141.
Ishii, T., M. Yamada, H. Sato, M. Matsue, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai (1993) Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
Ishinishi, N., A. Yamamoto, A. Hisanaga, and T. Inamasu (1983) Tumorigenicity of arsenic trioxide to the lung in syrian golden hamsters by intermittent instillations. Cancer Lett. 21: 141-147.
Ivhimiya, S., J. G. Davis, D. M. O''rourke, M. Katsumata, and M. I. Greene (1997) Murine Thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 16: 311-321.
Iwahara, S., H. Satoh, D. X. Song, J. Webb, A. L. Burlingame, Y. Nagae, and U. Muller-Eberhard (1995) Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34: 13398-13406.
Jin, D. Y., H. Z. Chae, S. G. Rhee, and K. T. Jeang (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-kB Activation. J. Biol. Chem. 272: 30952-30961.
Kang, S. W., I. C. Baines, and S. G. Rhee (1998) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273: 6303-6311.
Kang, S. W., H. Z. Chae, M. S. Seo, K. Kim, and I. C. Baines (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J. Biol. Chem. 273: 6297-6302.
Kawai, S., S. Takeshita, M. Okazaki, R. Kikuno, A. Kudo, and E. Amann (1994) Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J. Biochem. 115: 641-643.
Knowles, F. C., and A. A. Benson (1983) The biochemistry of arsenic. Trends Biochem. Sci. 8: 178-180.
Lee, T. C., and I. C. Ho (1995) Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch. Toxicol. 69: 498-504.
Lee, T. C., M. Oshimura, and J. C. Barrett (1985) Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in syrian hamster embryo cells in culture. Carcinogenesis 6: 1421-1426.
Lee, T. H., S. L. Yu, S. U. Kim, Y. M. Kim, I. Choi, S. W. Kang, S. G. Rhee, and D. Y. Yu (1999) Characterization of the murine gene encoding 1-Cys peroxiredoxin and identification of highly homologous genes. Gene 234: 337-344.
Lee, T. H., S. L. Yu, S. U. Kim, K. K. Lee, S. G. Rhee, and D. Y. Yu (1999) Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene 239: 243-250.
Lee, S. P., Hwang, Y. S., Y. J. Kim, Kwon, K. S.,H. J. Kim, K. Kim, and Chae, H. Z. (2001) Cyclophilin A binds to peroxiredoxins and activates its peroxidase activity. J. Biol. Chem. 276: 29826-29832.
Li. B., Ishii. T., Tan. C. P., Soh. J. W., and Stephen. S. P. (2002) Pathway of induction of peroxiredoxin I expression in osteoblasts. J. Biol. Chem. 277: 12418-12422.
Li, W., and I. N. Chou (1992) Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol. Appl. Pharmacol. 114: 132-139.
Lim, Y. S., M. K. Cha, C. H. Yun, H. K. Kim, K. Kim, and I. H. Kim (1994) Purification and characterization of thiol-specific antioxidant protein from human red blood cell: A new type of antioxidant protein. Biochem. Biophysiol. Res. Commun. 199: 199-206.
Liu, Y. C., and H. Huang (1997) Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell Biochem. 64: 423-433.
Lynn, S., J. N. Shiung, J. R. Gurr, and K. Y. Jan (1998) Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic. Biol. Med. 24: 442-449.
Mann, S., P. O. Droz, and M. Vahter (1996) Physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140: 471-486.
Mizusawa, H., T. Ishii, and S. Bannai (2000) Perosiredoxin I (macrophage 23 kDa stress protein ) is highly and widely expression in the rat nervous system. Neurosci. Lett. 283: 57-60.
Morton, W. E., and D. A. Dunnette (1994) Health effect of environmental arsenic. In Arsenic in the environment, New York.
Nishizuka, Y. (1984) The molecular heterogeneity of protein kinase C and implications for cellular regulation. Nature（London） 334: 661-665.
Nishizuka, Y. (1995) Proteinkinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496.
Prosperi, M. T., D. Ferbus, I. Karczinski, and G. Goubin (1993) A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268: 11050-11056.
Prosperi, M. T., D. Ferbus, D. Rouillard, and G. Goubin (1998) The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett. 423: 39-44.
Schroder, E., J. A. Littlechild, A. A. Lebedev, N. Errington, A. A. Vagin, and M. N. Isupov (2000) Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7Å resolution. Structure 8: 605-615.
Scott, N., K. M. Hatlelid, N. E. MacKenzie, and D. E. Carter (1993) Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6: 102-106.
Shau, H., L. H. Butterfield, R. Chiu, and A. Kim (1994) Cloning and sequencing analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 40: 129-134.
Shau, H., A. C. J. Huang, M. Faris, and R. Nazarian (1998) Thioredoxin peroxidase (Natural killer Enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophysiol. Res. Commun. 249: 683-686.
Sheehy, J. W., and J. H. Jones (1993) Assessment of arsenic exposures and controls in gallium arsenide production. Am. Ind. Hyg. Assoc. J. 54: 61-69.
Styblo, M., and D. J. Thomas (1997) Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol. 147: 1-8.
Sunderman, F. W. (1979) Mechanism of metal carcinogens. Biol. Trace. Elem. Res. 1: 53-86.
Tseng, C. H., C. K. Chong, C. J. Chen, and T. Y. Tai (1996) Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120: 125-133.
Tseng, W. P. (1977) Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic.Environ. Health. Perspect. 19: 109-119.
Tseng, W. P., H. M. Chu, S. W. How, J. M. Fong, C. S. Lin, and S. Yeh (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40: 453-463.
Vahter, M., and J. Envall (1983) In vivo reduction of arsenate in mice and rabbits. Environ. Res. 32: 14-24.
Wang, T. S., C. F. Kuo, K. Y. Jan, and H. Huang (1996) Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell. Physiol. 169: 256-268.
Wang, T. S., Y. F. Shu., Y.C. Liu., K.Y. Jan, and H. Huang (1997) Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicity.121: 229-237.
Watabe, S., H. Kohno, H. Kouyama, T. Hiroi, N. Yago, and T. Nakazawa (1994) Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J. Biochem. 115: 648-654.
Wen, S. T., and R. A. Van Etten (1997) The pag gene product, a stress-induced protein with antioxidant properties, is an Abl SH-3 binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11: 2456-2467.
Wen, W. N., T. L. Lieu, H. J. Chang, S. W. Wuu, M. L. Yau, and K. Y. Jan (1981) Baseline and sodium arsenite-induced sister chromatid exchange in cultured lympocytes from patients with Blackfoot disease and healthy persons. Hum. Genet. 59: 201-203.
Yamamoto, T., Y. Matsui, S. Natori, and M. Obinata (1989) Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80: 337-343.
Yamanaka, K., A. Hasegawa, R. Sawamura, and S. Okada (1991) Cellular response to oxidative damage in lung induced by the administration of dimethylarsenic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108: 205-213.
Yanagawa, T., T. Ishikawa, T. Ishii, K. Tabuchi, S. Iwasa, S. Bannai, K. Omura, H. Suzuki, and H. Yoshida (1999) Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 145: 127-132.
Yih, L. H., and T. C. Lee (1999) Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res. 440: 75-82.
Zhang, P., B. Liu, S. W. Kang, M. S. Seo, S. G. Rhee, and L. M. Obeid (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 272: 30615-30618.